7-羟基-5-氧代-1,2,3,5-四氢中氮茚-8-羧酸甲酯结构式
|
常用名 | 7-羟基-5-氧代-1,2,3,5-四氢中氮茚-8-羧酸甲酯 | 英文名 | Methyl 7-hydroxy-5-oxo-1,2,3,5-tetrahydroindolizine-8-carboxylate |
|---|---|---|---|---|
| CAS号 | 37704-45-3 | 分子量 | 209.19900 | |
| 密度 | 1.42g/cm3 | 沸点 | 362.6ºC at 760 mmHg | |
| 分子式 | C10H11NO4 | 熔点 | N/A | |
| MSDS | N/A | 闪点 | 173.1ºC |
| 中文名 | 7-羟基-5-氧代-1,2,3,5-四氢吲哚嗪-8-羧酸甲酯 |
|---|---|
| 英文名 | methyl 7-hydroxy-5-oxo-2,3-dihydro-1H-indolizine-8-carboxylate |
| 英文别名 | 更多 |
| 密度 | 1.42g/cm3 |
|---|---|
| 沸点 | 362.6ºC at 760 mmHg |
| 分子式 | C10H11NO4 |
| 分子量 | 209.19900 |
| 闪点 | 173.1ºC |
| 精确质量 | 209.06900 |
| PSA | 68.53000 |
| LogP | 0.28670 |
| InChIKey | FFBGMQGVKHQEEK-UHFFFAOYSA-N |
| SMILES | COC(=O)c1c(O)cc(=O)n2c1CCC2 |
| 折射率 | 1.605 |
| 储存条件 | 2-8°C |
| 海关编码 | 2933990090 |
|---|
|
~74%
7-羟基-5-氧代-1,2,3... 37704-45-3 |
| 文献:TAKEDA PHARMACEUTICAL COMPANY LIMITED Patent: US2009/124595 A1, 2009 ; Location in patent: Page/Page column 33 ; US 20090124595 A1 |
| 海关编码 | 2933990090 |
|---|---|
| 中文概述 | 2933990090. 其他仅含氮杂原子的杂环化合物. 增值税率:17.0%. 退税率:13.0%. 监管条件:无. 最惠国关税:6.5%. 普通关税:20.0% |
| 申报要素 | 品名, 成分含量, 用途, 乌洛托品请注明外观, 6-己内酰胺请注明外观, 签约日期 |
| Summary | 2933990090. heterocyclic compounds with nitrogen hetero-atom(s) only. VAT:17.0%. Tax rebate rate:13.0%. . MFN tariff:6.5%. General tariff:20.0% |
|
实验名称:Inhibition of the Burkholderia mallei acyl-homoserine lactone synthase BmaI1
来源:ICCB-Longwood/NSRB Screening Facility, Harvard Medical School
靶标:autoinducer synthetase family protein [Burkholderia mallei ATCC 23344]
External Id:HMS1126
|
|
实验名称:Discovery of Small Molecules to Inhibit Human Cytomegalovirus Nuclear Egress
来源:ICCB-Longwood/NSRB Screening Facility, Harvard Medical School
靶标:HCMV UL50
External Id:HMS1262
|
|
实验名称:A screen for compounds that inhibit the activity of LtaS in Staphylococcus aureus
来源:ICCB-Longwood/NSRB Screening Facility, Harvard Medical School
External Id:HMS979
|
| 7-hydroxy-5-oxo-1,2,3,5-tetrahydro-indolizine-8-carboxylic acid methyl ester |
| 8-ethoxycarbonyl-7-hydroxy-2,3-dihydro-1H-indolizin-5-one |
| methyl 7-hydroxy-5-oxo-1,2,3,5-tetrahydroindolizine-8-carboxylate |
| HMS1732K08 |